Allarity Therapeutics Inc... (ALLR)
0.84
-0.04 (-4.56%)
At close: Mar 04, 2025, 10:15 AM
Allarity Therapeutics Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 166K | 2.03M | 19.55M | 298K | 1.52M | 237.38K | 536.03K | 2.07M | 1.99M | 2.07K | 50.4K |
Short-Term Investments | n/a | n/a | 350K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 350K | 845K | 137K | n/a | 765.2K | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | 350K | n/a | n/a | 1.00 | n/a | 28.33K | n/a | n/a | n/a |
Receivables | 946K | 871K | 1.34M | 1.12M | 1.66M | n/a | 407.74K | 2.31K | 92.87K | n/a | n/a |
Inventory | n/a | n/a | -1.34M | n/a | -2K | n/a | 168.9K | 34.69K | 2.00 | n/a | n/a |
Other Current Assets | 859K | 2.07M | 36K | 174K | 77K | 1.97M | 193.07K | 2.26M | 859.67K | n/a | n/a |
Total Current Assets | 1.97M | 4.97M | 21.05M | 1.72M | 3.34M | 2.21M | 1.31M | 4.37M | 2.94M | 2.07K | 50.4K |
Property-Plant & Equipment | 20K | 27K | 94K | 352K | 437K | 55.7K | 21.76K | 68.51K | n/a | n/a | n/a |
Goodwill & Intangibles | 9.87M | 9.55M | 28.14M | 30.49M | 27.69M | 36.33M | n/a | 2.07M | 2.51M | 91.23K | 129.6K |
Total Long-Term Assets | 9.89M | 9.58M | 28.58M | 31.69M | 28.26M | 36.38M | 786.96K | 2.17M | 2.51M | 91.23K | 129.6K |
Total Assets | 11.86M | 14.54M | 49.63M | 33.4M | 31.61M | 38.59M | 2.09M | 6.54M | 5.45M | 93.3K | 180K |
Account Payables | 8.42M | 6.25M | 698K | 2.12M | 2.18M | 1.94M | 472.37K | 1.27M | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | 8.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.3M | 2.66M | 196K | 1.52M | 622K | 2.9M | n/a | n/a | n/a | 4.8K | 5.54K |
Other Current Liabilities | 4.39M | 2.27M | 19.77M | 1.84M | 1.88M | 592.14K | 1.23M | 62.58K | 518.15K | 9.63K | 7.01K |
Total Current Liabilities | 14.17M | 11.22M | 20.72M | 5.53M | 4.72M | 5.43M | 1.7M | 1.34M | 518.15K | 14.44K | 12.55K |
Long-Term Debt | n/a | 1.08M | 988K | 1.15M | 341K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 7.18M | -2.26M | 3.79M | 5.25M | n/a | 0.00 | -0.00 | 0.00 | 0.00 |
Total Long-Term Liabilities | 446K | 1.43M | 10.13M | 1.02M | 5.99M | 5.25M | n/a | 0.00 | -0.00 | 0.00 | 0.00 |
Total Liabilities | 14.61M | 12.65M | 30.85M | 6.55M | 10.7M | 10.69M | 1.7M | 1.34M | 518.15K | 14.44K | 12.55K |
Total Debt | 1.3M | 3.73M | 1.09M | 1.79M | 963K | 2.9M | n/a | n/a | n/a | 4.8K | 5.54K |
Common Stock | n/a | 2K | 810K | 1.62M | 924K | 386.07K | 195.81K | 154.81K | 120K | 190.1K | 215.99K |
Retained Earnings | -94.45M | -82.55M | -66.49M | -37.43M | -32.37M | -9.37M | -7.08M | n/a | -669.07K | -111.23K | -48.55K |
Comprehensive Income | -411K | -721K | -600K | 1.38M | -1.09M | 18.57K | -12.57K | -4.3M | -0.00 | -0.00 | n/a |
Shareholders Equity | -2.75M | 1.89M | 18.78M | 26.85M | 18.09M | 23.81M | 394.04K | 5.2M | 4.93M | 78.87K | 167.44K |
Total Investments | n/a | n/a | 350K | 845K | 137K | n/a | 765.2K | n/a | n/a | n/a | n/a |